je.st
news
Amgen drug fails to improve survival in multiple myeloma trial
2014-08-14 03:55:33| Biotech - Topix.net
Amgen Inc's Kyprolis drug failed to extend survival compared to standard care in a trial involving patients with advanced multiple myeloma, a type of blood cancer that develops in the bone marrow.
Tags: improve
multiple
trial
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||